Exascale Labs Holdings ( $XLAB) Slides -53% in 30 Days After Nasdaq Debut (See the latest news for any ticker on Tickeron.) Exascale Labs Holdings (XLAB) shares fell roughly 53% over the trailing 30 days, sliding from a closing price of $5.14 to $2.40. The decline followed the company's August 28, 2026 Nasdaq debut after completing a SPAC business combination, a period often marked by elevated volatility and selling pressure. Fiscal 2026 results reported 111.3% revenue growth to $14.8 million, but also a widening net loss of $12.2 million compared with $7.7 million in the prior year. $MSFT $ORCL $PANW $CRWD $XYZ
published
Exascale Labs Holdings ( $XLAB) Slides -53% in 30 Days After Nasdaq Debut (See the latest news for any ticker on Tickeron.) Exascale Labs Holdings (XLAB) shares fell roughly 53% over the trailing 30 days, sliding from a closing price of $5.14 to $2.40. The dec
$XLAB$MSFT$ORCL$PANW$CRWD$XYZ
Latest documented BWB result
$ASML market result
Exit $ASML with $5 profit per contract on the CDS
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.
